Works by Yamanda, Shinsuke


Results: 21
    1

    Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e536, doi. 10.1634/theoncologist.2019-0550
    By:
    • Aso, Mari;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Ogasawara, Takahiro;
    • Tsurumi, Kyoji;
    • Ono, Kana;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    2

    Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1358, doi. 10.1634/theoncologist.2017-0384
    By:
    • Toi, Yukihiro;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Tsurumi, Kyoji;
    • Suzuki, Kana;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Ono, Hirotaka;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro
    Publication type:
    Article
    3

    Adiponectin Pathway Attenuates Malignant Mesothelioma Cell Growth.

    Published in:
    American Journal of Respiratory Cell & Molecular Biology, 2012, v. 46, n. 4, p. 515, doi. 10.1165/rcmb.2011-0068OC
    By:
    • Kaijun Niu;
    • Masanori Asada;
    • Tatsuma Okazaki;
    • Shinsuke Yamanda;
    • Takae Ebihara;
    • Hui Guo;
    • Dongying Zhang;
    • Ryoichi Nagatomi;
    • Hiroyuki Arai;
    • Masahiro Kohzuki;
    • Satoru Ebihara
    Publication type:
    Article
    4

    Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancer.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 14, p. 4796, doi. 10.1002/cam4.4045
    By:
    • Ono, Kana;
    • Ono, Hirotaka;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aso, Mari;
    • Saito, Ryohei;
    • Kawana, Sachiko;
    • Aiba, Tomoiki;
    • Odaka, Tetsuo;
    • Matsuda, Suguru;
    • Saito, Shin;
    • Narumi, Akane;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy‐Induced Cytokine Release Syndrome.

    Published in:
    Cancer Reports, 2024, v. 7, n. 7, p. 1, doi. 10.1002/cnr2.2145
    By:
    • Minami, Soichiro;
    • Kawashima, Yosuke;
    • Munakata, Yasuhiko;
    • Matsuno, Masahiro;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    16

    Successful application of lorlatinib in a 23‐year‐old patient with anaplastic lymphoma kinase (ALK)‐positive lung cancer and multiple brain metastases.

    Published in:
    Cancer Reports, 2024, v. 7, n. 2, p. 1, doi. 10.1002/cnr2.1981
    By:
    • Murakami, Yosuke;
    • Kawashima, Yosuke;
    • Chiba, Shinji;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    17
    18
    19
    20
    21